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Abstract
Background: The purpose of this study was to clarify the characteristics of body composition and cardiometabolic
risk of Japanese male heavyweight Judo athletes compared with heavyweight athletes of other sports.
Methods: Nineteen heavyweight Judo athletes (mean age, 20.4 ± 1.1 years), as well as 22 heavyweight (mean age,
21.5 ± 0.9 years) and 17 nonheavyweight (mean age, 21.1 ± 0.8 years) American football and Rugby football athletes
in Japan participated in this study. Body composition was assessed by using dual-energy X-ray absorptiometry and
magnetic resonance imaging. Cardiometabolic risk was evaluated by measuring blood biochemical variables.
Results: Heavyweight Judo athletes had significantly heavier body mass (122.7 ± 13.1 kg vs. 99.0 ± 8.1 kg), higher
body fat percentage (27.5 % ± 5.2 % vs. 19.4 % ± 4.7 %), and larger visceral fat cross-sectional area (118 ± 35 cm2 vs.
67 ± 24 cm2) (P < 0.01) compared with heavyweight football players. Although the cardiometabolic risk was higher
in heavyweight athletes compared to nonheavyweight athletes, there were no significant differences between
heavyweight Judo and heavyweight Football athletes in the blood biochemical variables, except for high
concentration of uric acid in heavyweight Judo athletes.
Conclusions: Even though heavyweight Judo athletes had more excess fat mass, especially VF mass, their
cardiometabolic risk in terms of blood biochemical parameters was not significantly higher compared with
heavyweight athletes of other sports. Therefore, excessive fat accumulation may not necessarily increase
cardiometabolic risk for heavyweight Judo athletes.
Trial registration: This trial is registered with the University Hospital Medical Information Network Clinical Trial
Registration (UMIN-CTR) UMIN000020564.
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Background
Obesity, especially having visceral fat accumulation, is
known to be a major risk factor in cardiovascular disease
[1, 2]. Heavyweight athletes, including those who partici-
pate in Judo, American football, and Rugby football, often
intentionally try to increase their body mass (BM) because
it significantly influences their athletic performance [3].
However, it was recently reported that heavyweight athletes
have high cardiometabolic risk compared with nonheavy-
weight athletes, even though they are actively participating
in a sport [4–6]. Linemen in the National Football League
in the USA have higher body fat percentage compared with
players in other positions, and such excess body fat may in-
crease the risk of metabolic syndrome, when they are ac-
tively playing [4]. This association is seen not only in
Western athletes but also among Asian athletes [7]. Profes-
sional Chinese heavyweight athletes in strength sports in-
cluding Judo and Wrestling are at significantly higher risk
of cardiovascular disease compared with other sports or
athletes in lower body weight classes of a same sport [7].
The heaviest weight class in Judo, over 100 kg class for
male and over 78 kg for female does not have an upper
limit in their BM regulation when athletes enter compe-
titions. Therefore, Judo athletes in the heaviest weight
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class put significant effort toward maintaining or gaining
BM. In fact, a previous study showed that heavyweight
Judo athletes carry one of the heaviest BM and highest
body fat percentage compared with other heavyweight
athletes in other sports such as wrestlers and weightlif-
ters [7]. As a result, heavyweight Judo athletes may have
higher cardiometabolic risk compared with other heavy-
weight athletes. However, the previous study did not in-
vestigate body composition in detail, such as measuring
body fat percentage by using dual-energy X-ray absorpti-
ometry (DXA) and visceral fat (VF) by using magnetic
resonance imaging (MRI) in relationship with cardiomet-
abolic risk. If heavyweight Judo athletes indeed have high
cardiometabolic risk, such risk may harm their present
health. Furthermore, it may increase their risk of cardio-
vascular disease after they retire from their playing sport
[8]. Therefore, the purpose of this study was to clarify
the characteristics of body composition and cardiometa-
bolic risk of Japanese male heavyweight Judo athletes
compared with heavyweight athletes of other sports. We
hypothesized that because heavyweight Judo athletes had
higher body fat percentage [7], they expected to have
excessive VF mass and increase cardiometabolic risk
compared with heavyweight athletes in other sports.
Methods
Participants
We recruited 19 collegiate heavyweight Judo athletes
from the All Japan University Judo Championships team
as the heavyweight Judo group (mean age, 20.4 ±
1.1 years). In 19 heavyweight Judo athletes, 18 athletes
were categorized in over 100 kg weight class and one
athlete was categorized 100 kg weight class without
intentional weight loss. For comparison, 22 heavyweight
athletes (BM, >90 kg) were recruited from linemen on
an American football team and from forwards position
on a Rugby football team as the heavyweight football
group (mean age, 21.5 ± 0.9 years). Additionally, 17 non-
heavyweight athletes (BM, <90 kg) also were recruited
from the previously mentioned American football and
Rugby football teams as the nonheavyweight group
(mean age, 21.1 ± 0.8 years). These teams belonged to
the National Collegiate Athletic Association Division 1
in Japan. All participants in this study were adequately
informed about the study by verbal and written descrip-
tions, and each participant provided written informed
consent before starting the study. This study was ap-
proved by the Ethical Committee of Human Research of
Waseda University for use of human subjects in accord-
ance with the Declaration of Helsinki.
Design and procedure
The present cross-sectional study was designed to com-
pare heavyweight Judo athletes (heavyweight Judo group)
and heavyweight football athletes (BM, >90 kg; heavy-
weight football group). Additionally, in order to
emphasize the cardiometabolic risk of heavyweight ath-
letes, “heavyweight group,” which included both heavy-
weight Judo and heavyweight football athletes, was setup
to compare heavyweight and nonheavyweight athletes.
Lower weight class Judo athletes were excluded from
this study, since they were often involved in an
intentional weight loss which may influence their meta-
bolic state. We examined body composition parameters
in detail by using DXA and MRI, while cardiometabolic
risk was assessed by measuring blood biochemical vari-
ables in fasting state. All the measurements of partici-
pants were collected in the same laboratory facility in
the morning during in-season
Measurement of body composition parameters
BM was measured to the nearest 0.1 kg by using an elec-
tronic scale (UC-321; A&D, Tokyo, Japan) under fasting
condition in the morning. Body height was measured to
the nearest 0.1 cm by using a stadiometer (YL-65;
YAGAMI, Nagoya, Japan) with minimal clothing. Body
mass index (BMI) was calculated from the measured BM
(kg) and height (m). Body fat percentage was assessed by
using DXA (Hologic QDT-4500; Hologic, Waltham,
MA, USA). Total fat mass and fat-free mass (FFM) were
calculated from BM and body fat percentage. Waist cir-
cumference was measured to the nearest 0.1 cm by
using an inelastic measuring tape at the midpoint be-
tween the inferior coastal margin and the superior
border of the iliac crest. VF and subcutaneous fat (SF)
cross-sectional areas were measured by using MRI
(Signa 1.5T; General Electric Co., Milwaukee, WI, USA).
Imaging conditions included a T1-weighted spin-echo
and axial-plane sequence with a slice thickness of
10 mm, repetition time of 140 ms, and echo time of
12.3 ms. Cross-sectional images were scanned at the L4-
5 level, which was commonly used in previous studies,
especially in obese populations [9]. During scanning,
subjects were required to hold their breath for approxi-
mately 30 s after inhalation to reduce respiratory motion
artifacts. The images were transferred to a personal
computer in DICOM file format. VF and SF cross-
sectional areas were determined using digital image ana-
lysis software (Slice-O-Matic 4.3 for Windows; Tomovi-
sion, Montreal, Canada). To minimize interobserver
variation, all analyses were performed by the same inves-
tigator. The coefficient of variation was 2.4 % for VF
cross-sectional area and 0.1 % for SF, respectively.
Collection and analysis of blood samples
Venous blood samples were collected between 7:00 AM
and 10:00 AM after at least 12 h of overnight fasting. As-
partate aminotransferase (AST), alanine aminotransferase
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(ALT), and γ-glutamyl transpeptidase (γ-GTP) were used
as indices of liver function. Total cholesterol, high-density
lipoprotein cholesterol (HDL-C), and triglycerides (TGs)
were analyzed as indices of the lipid profile. Low-density
lipoprotein cholesterol (LDL-C) was calculated using the
Friedewald equation [10]. Uric acid concentration (UA)
was used as the index of uric acid metabolism. Further-
more, plasma glucose, serum insulin, and homeostasis
model assessment insulin resistance (HOMA-IR) were
assessed as indices of glucose metabolism. HOMA-IR was
calculated from plasma glucose and serum insulin concen-
trations. All blood parameters were analyzed by Mitsubishi
Chemical Medience, Inc. (Tokyo, Japan).
Statistical analyses
All statistical analyses were performed using SPSS version
22.0 (SPSS, Chicago, IL, USA). We examined differences
in body composition variables and blood biochemical vari-
ables between heavyweight athletes group and nonheavy-
weight athletes group as well as the heavyweight Judo
athletes group and heavyweight football athletes group
using the unpaired t test. Non-normally distributed vari-
ables were log transformed for analysis. Prevalence of each
cardiometabolic risk factor was compared between heavy-
weight Judo, heavyweight football, and nonheavyweight
groups using the chi-square test. All measurements
were presented as mean ± SD or median (from 25 to
75 % quartile range). The statistical significance level
was set at P < 0.05.
Results
Body composition
The comparison of body composition variables be-
tween heavyweight group and nonheavyweight group
was presented in Table 1. All body composition pa-
rameters were significantly higher in the heavyweight
group, except for body height. Table 2 showed the
comparison of body composition parameters between
heavyweight Judo and heavyweight football groups.
The heavyweight Judo group showed significantly
higher values in the parameters of fatness compared
with the heavyweight football group such as total fat
percentage and VF.
Cardiometabolic risk
The comparison of blood biochemical variables be-
tween heavyweight group and nonheavyweight group
were presented in Table 3. ALT, γ-GPT, UA, glucose,
insulin, and HOMA-IR in heavyweight group were sig-
nificantly higher than in nonheavyweight group. Table 4
showed the comparison of blood biochemical variables
between heavyweight Judo group and heavyweight foot-
ball. Only UA concentration was significantly higher in
the heavyweight Judo group compared with in the
heavyweight football group. Figure 1 showed the preva-
lence of cardiometabolic risk assessed by blood bio-
chemical analysis in all three groups. The prevalence of
abnormally high ALT in both the heavyweight Judo and
heavyweight football groups was significantly higher
than that in the nonheavyweight group. Additionally,
the prevalence of abnormally high UA and TG levels in
the heavyweight Judo group was significantly higher
than those in the nonheavyweight group. The preva-
lence of other components, such as AST, γ-GTP, HDL-
C, LDL-C, and HOMA-IR, were not significantly differ-
ent between the three groups.
Table 1 Comparison of body composition variables between
heavyweight and nonheavyweight groups
Heavyweight Nonheavyweight P
value†(n = 41) (n = 17)
Height (cm) 177.4 ± 5.7 175.6 ± 3.9 0.218
Body mass (kg)† 110.0 ± 16.0 78.9 ± 5.0 <0.001
BMI (kg/m2) 35.0 ± 4.9 25.6 ± 1.9 <0.001
Total fat percentage (%) 23.2 ± 6.0 13.0 ± 2.6 <0.001
fat mass (kg)† 26.2 ± 10.1 10.3 ± 2.6 <0.001
fat free mass (kg) 83.8 ± 8.1 68.5 ± 3.4 <0.001
Waist circumference (cm) 103 ± 10 82 ± 4 <0.001
VF (cm2)† 91 ± 39 33 ± 14 <0.001
SF (cm2) 321 ± 135 94 ± 46 <0.001
Data were expressed as mean ± SD. BMI body mass index, VF visceral fat area, SF
subcutaneous fat area; *Log-transformed variables for non-normally distributed
variables (body mass, total fat mass, VF) were used. †P value for difference
between heavyweight Judo and football groups was assessed by unpaired t test.
Significant differences, P < 0.05
Table 2 Comparison of body composition variables between
heavyweight Judo and football groups
Heavyweight (n = 41) P value†
Judo (n = 19) Football (n = 22)
Height (cm) 177.2 ± 6.1 177.6 ± 5.6 0.837
Body mass (kg)* 122.7 ± 13.1 99.0 ± 8.1 <0.001
BMI (kg/m2) 39.1 ± 3.8 31.4 ± 2.3 <0.001
Total fat percentage (%) 27.5 ± 5.2 19.4 ± 3.7 <0.001
fat mass (kg)* 34.1 ± 8.8 19.4 ± 4.7 <0.001
fat free mass (kg) 88.6 ± 8.0 79.7 ± 5.5 0.005
Waist circumference (cm) 111 ± 7 96 ± 7 <0.001
VF (cm2)* 118 ± 35 67 ± 24 <0.001
SF (cm2) 433 ± 100 223 ± 70 <0.001
Data were expressed as mean ± SD. BMI body mass index, VF visceral fat area, SF
subcutaneous fat area; *Log-transformed variables for non-normally distributed
variables (body mass, total fat mass, VF) were used. †P value for difference
between heavyweight Judo and football groups was assessed by unpaired t test.
Significant differences, P < 0.05
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Discussion
This study examined the characteristics of body com-
position and cardiometabolic risk in heavyweight Judo
athletes compared with heavyweight athletes in other
sports. Our main finding in this study was that although
heavyweight Judo athletes had higher body fat percent-
age and more fat mass, especially VF, their cardiometa-
bolic risk in terms of blood biochemical parameters was
not significantly higher than that in heavyweight football
athletes. Mean BM of the heavyweight Judo group was
approximately 20 kg heavier, and mean body fat percent-
age was approximately 8 % higher than those of the
heavyweight football group. Additionally, VF area of the
heavyweight Judo group was about two times larger than
that of the heavyweight football group (Table 2). Previ-
ous studies of non-athletes showed that cardiovascular
disease was associated with accumulation of excess VF
[11, 12]. Therefore, we expected that the heavyweight
Judo group would have higher cardiometabolic risk com-
pared with the heavyweight football group. However,
most blood biochemical variables were not significantly
different between both heavyweight groups, except for
UA concentration (Table 4). It is difficult to explain why
the large fat mass of the heavyweight Judo group did not
increase their cardiometabolic risk such as lipid profile
and insulin relative to the heavyweight football group
from results of this study. However, simply having more
fat mass may not necessarily increase cardiometabolic
risk in athletes. Previous studies reported the existence
of metabolically healthy obese individuals, who have
low risk of cardiovascular disease and insulin resistance
[13, 14]. For example, a follow-up study of metabolic-
ally healthy obese Italian individuals showed no in-
crease in cardiovascular disease risk over 15 years [15].
Although the mechanism of metabolically healthy obes-
ity is not clearly understood, it has been reported that
increased physical activity may offset the high risk of
cardiovascular disease in these individuals [16]. Add-
itionally, another previous study reported that a high
level of cardiorespiratory fitness was associated with
lower prevalence of metabolic risk, even among obese
individuals [17]. The heavyweight Judo athletes in this
study participated in daily training for approximately
3 h including not only strength exercises but also a lot
of high-intensity intermittent exercises which require
physiological endurance. In fact, high-intensity inter-
mittent exercise is a specific modality of Judo training
[18]. Such training programs may help to increase their
physical activity level and cardiorespiratory fitness re-
gardless of their heavy BM [19, 20]. Previous study
demonstrated that male heavyweight Judo athletes in
elite team have comparable aerobic capacity to profes-
sional defensive linemen as heavyweight football ath-
letes [21, 22]. Therefore, Judo athletes may be similarly
Table 3 Comparison of blood biochemical parameters between
heavyweight and nonheavyweight groups
Heavyweight Nonheavyweight P value‡ Normal
range(n = 41) (n = 17)
AST* (U/L) 28 (24–38) 24 (20–30) 0.053 10–40
ALT* (U/L) 38 (29–49) 20 (15–27) <0.001 5–45
γ-GTP* (U/L) 32 (26–44) 23 (15–26) <0.001 <80
Total-C (mg/dL) 179 ± 32 179 ± 31 0.966 120–219
HDL-C (mg/dL) 48 ± 8 51 ± 6 0.220 40–85
LDL-C† (mg/dL) 105 ± 30 109 ± 24 0.581 ≦140
TG* (mg/dL) 112 (75–165) 80 (66–110) 0.086 30–149
UA (mg/dL) 6.9 ± 1.5 6.2 ± 1.0 0.048 3.8–7.0
FPG* (mg/dL) 85 (82–91) 80 (78–84) 0.012 70–109
Insulin* (μIU/mL) 8.4 (5.7–11.3) 5.3 (4.4–6.5) 0.011 1.7–10.4
HOMA-IR* 1.72 (1.13–2.52) 1.02 (0.91–1.36) 0.008 <2.50
Data were expressed as mean± SD or median (inter quartile range). AST aspartate
aminotransferase, ALT alanine aminotransferase, γ-GTP γ-glutamyl transpeptidase,
Total-C total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-
density lipoprotein cholesterol, TG triglyceride, UA uric acid, FPG fasting
plasma glucose, HOMA-IR homeostasis model assessment insulin resistance,
*Log-transformed variables for non-normally distributed variables (AST, ALT,
γ-GTP, TG, FPG, insulin, HOMA-IR) were used to analysis. †The low-density
lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation. ‡P
value for difference between heavyweight and nonheavyweight groups was
assessed by unpaired t test. Significant differences, P < 0.05
Table 4 Comparison of blood biochemical parameters between
heavyweight Judo and football groups
Heavyweight (n = 41) P value‡ Normal
rangeJudo (n = 19) Football (n = 22)
AST* (U/L) 28 (20–44) 30 (24–37) 0.856 10–40
ALT* (U/L) 36 (23–54) 40 (31–48) 0.872 5–45
γ-GTP* (U/L) 29 (23–43) 35 (28–47) 0.371 <80
Total-C (mg/dL) 174 ± 33 183 ± 31 0.373 120–219
HDL-C (mg/dL) 47 ± 8 49 ± 8 0.470 40–85
LDL-C† (mg/dL) 96 ± 35 112 ± 24 0.107 ≦140
TG* (mg/dL) 135 (90–185) 103 (66–131) 0.107 30–149
UA (mg/dL) 7.4 ± 1.3 6.4 ± 1.5 0.026 3.8–7.0
FPG* (mg/dL) 83 (79–90) 87 (83–91) 0.333 70–109
Insulin* (μIU/mL) 8.6 (4.9–11.7) 7.7 (5.8–11.4) 0.707 1.7–10.4
HOMA-IR* 1.99 (1.05–2.42) 1.58 (1.16–2.77) 0.631 <2.50
Data were expressed as mean± SD or median (inter quartile range). AST aspartate
aminotransferase, ALT alanine aminotransferase, γ-GTP γ- glutamyl transpeptidase,
Total-C total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-
density lipoprotein cholesterol, TG triglyceride, UA uric acid, FPG fasting
plasma glucose, HOMA-IR homeostasis model assessment insulin resistance;
*Log-transformed variables for non-normally distributed variables (AST, ALT,
γ-GTP, TG, FPG, insulin, HOMA-IR) were used to analysis. †The low-density
lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation. ‡P
value for difference between heavyweight Judo and Football groups were
assessed by unpaired t test. Significant differences, P < 0.05
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metabolically active as heavyweight football players,
and simply having more fat mass does not automatic-
ally increase cardiometabolic risk for athletes. At the
same time, those heavyweight athletes still have higher
risk of cardiometabolic risk compared to nonheavy-
weight athletes. Therefore, periodic biochemical tests to
assess such risks are suggested to detect heavyweight
athletes at high cardiometabolic risk. We should also
note that only UA concentration was higher in the
heavyweight Judo group compared with in the heavy-
weight football group (Table 4). The high concentration
of UA is known to cause gout, and it has been reported
that VF is the most influential factor in UA concentra-
tion [23]. Therefore, the larger VF mass of the heavy-
weight Judo athletes may have increased their UA
concentration. At the same time, it has been reported
that UA metabolism is influenced by both dietary in-
take and physical exercise [24]. High intake of meat
and fish is known to be the dietary cause of increase in
blood UA level. Heavyweight Judo athletes in this study
may have a high intake of meat products to increase
their energy and protein intake to gain BM as muscle
mass. Moreover, high-intensity intermittent exercise in-
crease hypoxanthine and UA metabolism [25]. There-
fore, it is possible that diet and exercise may influence
the UA level of heavyweight Judo athletes besides
their large VF mass. However, diet and exercise were
not assessed in this study. Therefore, further study to
evaluate the influence of diet and/or exercise on car-
diometabolic risk, including UA concentration, will
help to elucidate the development of risk in heavy-
weight athletes.
The prevalence of abnormally high UA and TG levels
was higher in the heavyweight Judo group compared
with those in the nonheavyweight group (Fig. 1), even
though mean UA and TG levels in the heavyweight Judo
group were within or close to the reference normal
range (Table 4). In other words, there are several heavy-
weight Judo athletes in this study who had abnormally
high levels of UA and/or TG, but most of the heavy-
weight athletes were within its normal ranges by observ-
ing the individual results. Those athletes with higher UA
and/or TG level did not necessarily carry more fat mass
or VF mass. Additionally, there were no other anthropo-
metric parameters commonly found in those who had
abnormal blood biochemical parameters among Judo
athletes. Therefore, athletes with increased cardiomet-
abolic risk may be influenced by other factors such as
genetic factors [26, 27], dietary habits [28, 29], or
other lifestyle factors commonly related with cardio-
metabolic risks.
The present study has a few limitations. Firstly, this
study design was a cross-sectional study, and thus, it is
difficult to determine the cause and effect relationship in
this study. Furthermore, larger sample sizes, prospective
and interventional studies, are required to investigate
the physiological mechanism of decreasing cardiometa-
bolic risk in heavyweight Judo athletes despite their
excessive fat mass.
Conclusion
Cardiometabolic risk in Japanese male heavyweight Judo
athletes was not significantly higher compared with
other heavyweight athletes, even though they had higher
fat mass such as VF. Therefore, excessive fat accumula-
tion may not necessarily increase cardiometabolic risk
for heavyweight Judo athletes.
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Fig. 1 Comparison of prevalence in cardiometabolic risk in terms of blood biochemical parameters. Prevalence of cardiometabolic risk presents
the percentage over the referenced normal range of respective parameters. The cut-off referenced normal range were as follows: AST < 40 (U/L),
ALT < 45 (U/L), γ-GTP≧ 80 (U/L), HDL-C < 40 (mg/dL), LDL-C≦ 140 (mg/dL), TG≧ 150 (mg/dL), UA > 7.0 (mg/dL), HOMA-IR≧ 2.5. *Significant
differences compared with Nonheavyweight group, P < 0.05
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